➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Johnson and Johnson
AstraZeneca
McKesson
Colorcon

Last Updated: February 24, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR METHYLPREDNISOLONE SODIUM SUCCINATE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Methylprednisolone Sodium Succinate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000579 Acute Respiratory Distress Syndrome Clinical Network (ARDSNet) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1994-09-01 The purposes of this study are to assess rapidly innovative treatment methods in patients with adult respiratory distress syndrome (ARDS) as well as those at risk of developing ARDS and to create a network of interactive Critical Care Treatment Groups (CCTGs) to establish and maintain the required infrastructure to perform multiple therapeutic trials that may involve investigational drugs, approved agents not currently used for treatment of ARDS, or treatments currently used but whose efficacy has not been well documented.
NCT00290602 Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome Completed National Cancer Center, Korea Phase 2 2004-02-01 The purpose of this study is to determine whether the 2mg/kg administration of corticosteroids, in the form of methylprednisolone sodium succinate, in early phase acute respiratory distress syndrome after thoracic surgery, will reduce the postoperative mortality.
NCT00295269 Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1997-03-01 The purpose of this study is to assess innovative treatment methods in patients with adult respiratory distress syndrome (ARDS) as well as those at risk of developing ARDS.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Methylprednisolone Sodium Succinate

Condition Name

Condition Name for Methylprednisolone Sodium Succinate
Intervention Trials
Lung Diseases 2
Acute Respiratory Distress Syndrome 2
Spinal Cord Injuries 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Methylprednisolone Sodium Succinate
Intervention Trials
Syndrome 5
Respiratory Distress Syndrome, Newborn 3
Respiratory Distress Syndrome, Adult 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Methylprednisolone Sodium Succinate

Trials by Country

Trials by Country for Methylprednisolone Sodium Succinate
Location Trials
United States 68
Canada 9
Australia 5
New Zealand 2
China 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Methylprednisolone Sodium Succinate
Location Trials
North Carolina 3
Maryland 3
Louisiana 3
Massachusetts 3
Ohio 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Methylprednisolone Sodium Succinate

Clinical Trial Phase

Clinical Trial Phase for Methylprednisolone Sodium Succinate
Clinical Trial Phase Trials
Phase 4 3
Phase 3 6
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Methylprednisolone Sodium Succinate
Clinical Trial Phase Trials
Completed 8
Not yet recruiting 7
Recruiting 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Methylprednisolone Sodium Succinate

Sponsor Name

Sponsor Name for Methylprednisolone Sodium Succinate
Sponsor Trials
China Spinal Cord Injury Network 2
National Cancer Institute (NCI) 2
National Heart, Lung, and Blood Institute (NHLBI) 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Methylprednisolone Sodium Succinate
Sponsor Trials
Other 20
NIH 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Harvard Business School
Dow
Moodys
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.